http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113694069-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4706
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4706
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2021-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2022-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-113694069-B
titleOfInvention A kind of preparation method of compound liposome co-loaded with evodiamine and chloroquine phosphate
abstract The invention relates to the technical field of medicine, and discloses a method for preparing a compound liposome co-loaded with evodiamine and chloroquine phosphate, including the preparation of EVO-Lips and the preparation of EVO-CQ-Lips; and a compound liposome and a compound liposome are also disclosed. application. The present invention encapsulates CQ and EVO together in liposomes to prepare compound liposomes. The compound liposomes can effectively and accurately act on breast cancer cells in vivo, thereby improving the bioavailability of EVO in vivo and reducing CQ The killing effect on normal tissue cells has little side effect, and can synergistically play a lasting role in the cancer site, synergistically kill tumor cells, and make the therapeutic effect more rapid and efficient.
priorityDate 2021-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4948
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID567419
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2719
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419475332
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419519896
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447827115
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1150
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415966911
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2539239
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447917096
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65079
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID855668
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24538
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10147142
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID354523
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504623
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426434452
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6212
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53868223
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID354523
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21225616
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID442088
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID18431
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415956444
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID397926
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID390986
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414780683

Total number of triples: 49.